"Anti-Asthmatic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are used to treat asthma.
| Descriptor ID |
D018927
|
| MeSH Number(s) |
D27.505.954.796.050
|
| Concept/Terms |
Anti-Asthmatic Agents- Anti-Asthmatic Agents
- Agents, Anti-Asthmatic
- Anti Asthmatic Agents
- Anti-Asthmatics
- Anti Asthmatics
- Antiasthmatic Drugs
- Drugs, Antiasthmatic
- Antiasthmatics
- Anti-Asthmatic Drugs
- Anti Asthmatic Drugs
- Drugs, Anti-Asthmatic
- Antiasthmatic Agents
- Agents, Antiasthmatic
|
Below are MeSH descriptors whose meaning is more general than "Anti-Asthmatic Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Asthmatic Agents".
This graph shows the total number of publications written about "Anti-Asthmatic Agents" by people in this website by year, and whether "Anti-Asthmatic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 2 | 1 | 3 |
| 1999 | 0 | 1 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 1 | 3 |
| 2010 | 2 | 3 | 5 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 2 | 3 |
| 2014 | 2 | 1 | 3 |
| 2015 | 4 | 0 | 4 |
| 2016 | 2 | 2 | 4 |
| 2017 | 4 | 1 | 5 |
| 2018 | 7 | 0 | 7 |
| 2019 | 6 | 1 | 7 |
| 2020 | 7 | 1 | 8 |
| 2021 | 4 | 1 | 5 |
| 2022 | 7 | 0 | 7 |
| 2023 | 6 | 1 | 7 |
| 2024 | 5 | 1 | 6 |
| 2025 | 6 | 1 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Asthmatic Agents" by people in Profiles.
-
Identifying Treatable Traits of Patients with Asthma Prescribed an ICS/LABA: A Descriptive Analytic Database Study in England. Adv Ther. 2025 Oct; 42(10):5164-5186.
-
Biologics for severe asthma: deciphering what is best for the patient. Expert Rev Clin Immunol. 2025 Aug; 21(8):1035-1054.
-
Burden of Oral Corticosteroid Use in Severe Asthma: Challenges and Opportunities. Allergy. 2025 Aug; 80(8):2113-2127.
-
The interplay between asthma and type 2 diabetes mellitus: mutual interactions and therapeutic implications. Expert Rev Clin Immunol. 2025 Jun; 21(6):683-699.
-
Comparative effectiveness of inhaled fluticasone propionate/salmeterol and budesonide/formoterol fixed-dose combinations in asthma control - a retrospective United States database analysis. Respir Med. 2025 Aug-Sep; 245:108172.
-
Asthma in the Biologics Era: Should Oral Corticosteroid Therapy Be Relegated to History? J Allergy Clin Immunol Pract. 2025 Jul; 13(7):1559-1568.
-
Asthma outcomes in a safety net hospital system: A comparative study to a national cohort. Respir Med. 2025 Apr-May; 240:108032.
-
Promoting Prevention and Targeting Remission of Asthma: A EUFOREA Consensus Statement on Raising the Bar in Asthma Care. Chest. 2025 Apr; 167(4):956-974.
-
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences. Drugs. 2024 Oct; 84(10):1251-1273.
-
Biologics in Asthma: Emerging Biologics. Immunol Allergy Clin North Am. 2024 11; 44(4):751-763.